Adenosine regulates the production of interleukin-6 by human gingival fibroblasts via cyclic AMP/protein kinase A pathway

Journal of Periodontal Research

Volumn 35, Issue 2, 2000, Pages 93-101

  Murakami, Shinya ^a   Terakura, Mami ^a   Kamatani, Takeyuki ^a   Hashikawa, Tomoko ^a   Saho, Teruyuki ^a   Shimabukuro, Yoshio ^a   Okada, Hiroshi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Adenosine; Cyclic amp protein kinase A; Human gingival fibroblast; Interleukin 6

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 6;

ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FIBROBLAST; GINGIVA; HUMAN; METABOLISM; PERIODONTITIS; PHYSIOLOGY; STIMULATION;

2-CHLOROADENOSINE; ADENOSINE; ADJUVANTS, IMMUNOLOGIC; ANALYSIS OF VARIANCE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-6; PERIODONTITIS; STIMULATION, CHEMICAL;

EID: 0034168944     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2000.035002093.x     Document Type: Article

References (49)

1. Barankiewicz J, Ronlov G, Jimenez R, Gruber HE. Selective adenosine release from human B but not T lymphoid cell line. J Biol Chem 1990;265:15738-15743.
2. Barankiewicz J, Jimenez R, Ronlov G, Magill M, Gruber HE. Alteration of purine metabolism by AICA-riboside in human B lymphoblasts. Arch Biochem Biophys 1990;282: 377-385.
3. Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991;88:2441-2445.
4. Gunther GR, Herring MB. Inhibition of neutrophil superoxide production by adenosine released from vascular endothelial cells. Ann Vasc Surg 1991;5:325-330.
5. Smolenski RT, Kochan Z, McDouall R, Page C, Seymour AL, Yacoub MH. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res 1994;28:100-104.
6. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92: 2675-2682.
7. Cronstein BN, Naime D, Ostad E. The antiinflammatory effects of methotrexate are mediated by adenosine. Adv Exp Med Biol 1994;370:411-416.
8. Gadangi P, Longaker M, Naime D et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 1996; 156:1937-1941.
9. Hirschhorn R, Roegner Maniscalco V, Kuritsky L, Rosen FS. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J Clin Invest 1981;68: 1387-1393.
10. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Phvsiol 1986; 61:1667-1676.
11. Asako H, Wolf RE, Granger DN. Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology 1993;104:31-37.
12. Cronstein BN, Naime D, Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 1995;38:1040-1045.
13. Cronstein BN. The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism. Br J Rheumatol 1995;2:30-32.
14. Parmely MJ, Zhou WW, Edwards CKD, Borcherding DR, Silverstein R, Morrison DC. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 1993;151:389-396.
15. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153:4159-4168.
16. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 1996;156:3435-3442.
17. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996;157:4634-4640.
18. Le Moine O, Stordeur P, Schandene L et al. Adenosine enhances IL-10 secretion by human monocytes. J Immunol 1996;156:4408-4414.
19. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 1992; 148:2201-2206.
20. Firestein GS, Bullough DA, Erion MD et al. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol 1995;154: 326-334.
21. Dendorfer U. Molecular biology of cytokines. Artif Organs 1996;20:437-444.
22. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990;4:2860-2867.
23. Ito H, Harada Y, Matsuo T, Ebisu S, Okada H. Possible role of T cells in the establishment of IgG plasma cell-rich periodontal lesion-augmentation of IgG synthesis in the polyclonal B cell activation response by autoreactive T cells. J Periodont Res 1988;23:39-45.
24. Harada Y, Ito H, Miki Y, Ebisu S, Okada H. Polyclonal induction of IgG antibody forming cells by stimulation with Actinomyces viscosus T14V. J Periodont Res 1988;23: 122-126.
25. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 1994;14:4443-4454.
26. Kiriyama Y, Murayama T, Tokumitsu Y, Nomura Y. Protein kinase A-dependent IL-6 production induced by calcitonin in human glioblastoma A172 cells. J Neuroimmunol 1997;76:139-144.
27. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 1988;263:6177-6182.
28. Zitnik RJ, Zheng T, Elias JA. cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts. Am J Physiol 1993;264:L253-L260.
29. Takada H, Mihara J, Morisaki I, Hamada S. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun 1991;59:295-301.
30. Tamura M, Tokuda M, Nagaoka S, Takada H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Poryphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun 1992;60:4932-4937.
31. Okada N, Kobayashi M, Mugikura K et al. Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid. J Periodont Res 1997;32:559-569.
32. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995;35:581-606.
33. Resta R, Thompson LF. SCID: the role of adenosine deaminase deficiency. Immunol Today 1997;18:371-374.
34. Green PG, Basbaum AI, Helms C, Levine JD. Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc Natl Acad Sci USA 1991;88:4162-4165.
35. Le JM, Weinstein D, Gubler U, Vilcek J. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol 1987;138:2137-2142.
36. Dalton BJ, Connor JR, Johnson WJ. Interleukin-1 induces interleukin-1 alpha and interleukin-1 beta gene expression in synovial fibroblasts and peripheral blood monocytes. Arthritis Rheum 1989;32:279-287.
37. Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993;3:9-38.
38. Bucala R, Ritchlin C, Winchester R, Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 1991;173: 569-574.
39. Elias JA, Reynolds MM, Kotloff RM, Kern JA. Fibroblast interleukin 1 beta: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation. Proc Natl Acad Sci USA 1989;86: 6171-6175.
40. Rios M, Williams DA. Systematic analysis of the ability of stromal cell lines derived from different murine adult tissues to support maintenance of hematopoietic stem cells in vitro. J Cell Physiol 1990;145:434-443.
41. Hou L, Ravenall S, Macey MG, Harriott P, Kapas S, Howells GL. Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts. J Periodont Res 1998;33:205-211.
42. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994;76:5-13.
43. van Calker D, Muller M, Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 1979; 33:999-1005.
44. Taussig R, Gilman AG. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 1995;270:1-4.
45. Sunahara RK, Dessauer CW, Gilman AG. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 1996;36:461-480.
46. Cooper DM, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 1995;374:421-424.
47. Sexl V, Mancusi G, Holler C, Gloria Maercker E, Schutz W, Freissmuth M. Stimulation of the mitogen-activated protein kinase via the A2a-adenosine receptor in primary human endothelial cells. J Biol Chem 1997;272: 5792-5799.
48. Xia Y, Fertel RH, Wood JD. Suppression of cAMP formation by adenosine in myenteric ganglia from guinea-pig small intestine. Eur J Pharmacol 1997;320: 95-101.
49. Taussig R, Quarmby LM, Gilman AG. Regulation of purified type I and type II adenylylcyclases by G protein beta gamma subunits. J Biol Chem 1993;268: 9-12.